Guo Rui Yinuo has been recognized by the Xi'an Municipal Science and Technology Bureau as the Xi'an Engineering and Technology Research Center for 2022.
Release time:
2023-09-25 17:02
Keywords:
September 25 , Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd. was Xi'an Municipal Science and Technology Bureau Recognized as “ Fiscal Year 2022 Xi'an City Engineering and Technology Research Center ”。


The Engineering Technology Research Center is an industrial technology innovation platform dedicated to conducting engineering research and development, breaking through common industry challenges and key technologies, accelerating the transfer, dissemination, and diffusion of scientific and technological achievements, and leading technological advancement in the industry. Guo Rui Yinuo, through Xi'an City... Engineering and Technology Research Center Once recognized, it will serve as a crucial intermediate link in the transformation of innovative drugs from the innovation chain to the industrial chain, and will further take on responsibilities. The interactive integration of the innovation chain and industrial chain in the life sciences sector within “Qin Chuang Yuan” holds significant value for the development of the province’s life sciences industry.
Guo Rui Yi Nuo Yu In July 2021, we obtained the National Medical Products Administration’s GLP (Good Laboratory Practice) certification for pharmaceuticals, filling a gap in GLP laboratories in our province. This will establish a convenient, efficient, and reliable technical platform for new drug research and preclinical safety evaluation in Shaanxi Province’s pharmaceutical industry, playing a significant role in further enhancing Shaanxi Province’s drug R&D capabilities, its independent innovation capacity in the pharmaceutical sector, and the overall quality of drug research. In August 2022, Guorui Yinuo passed the veterinary drug GLP certification administered by the Ministry of Agriculture and Rural Affairs of China, and in May 2023, it received the “Certificate of Conformity to Good Laboratory Practice” (CNAS GLP) from the China National Accreditation Service for Conformity Assessment.
Guo Rui Yinuo’s building area reaches 4,200 square meters, with Phase I investment exceeding 30 million yuan, currently equipped with a liquid chromatography-mass spectrometry system, high-performance liquid chromatograph, fully automatic chemiluminescence analyzer, animal blood analyzer, automated tissue dehydrator, pathology diagnostic microscopy system, microscale laboratory balance, and animals... Inhalation exposure system for substances through the mouth and nose Atomic Absorption Spectrophotometer Atomic fluorescence spectrophotometer, Ultraviolet-Visible Spectrophotometer, etc. We have more than 300 sets of instruments and equipment, and have established experimental platforms covering genetic toxicology, reproductive toxicology, analytical testing, and clinical pathology. Our company is dedicated to non-clinical safety evaluation of drugs, offering clients a one-stop service that includes personalized protocol design, drug screening, pharmacodynamic studies, pharmacokinetic studies, safety assessments, and clinical trial sample analysis. We also provide services for safety evaluations of food, health supplements, cosmetics, and medical devices. In addition, our company has set up platforms for the development of disease model animals and the breeding of laboratory animals. We have assembled a stable, experienced, and highly qualified professional team and have established a GLP system that simultaneously complies with the regulatory requirements of the U.S. FDA, the OECD, and China’s NMPA.
Related News